A detailed history of Raymond James & Associates transactions in Evolent Health, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 17,598 shares of EVH stock, worth $432,382. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,598
Previous 17,349 1.44%
Holding current value
$432,382
Previous $331,000 50.15%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$18.41 - $32.97 $4,584 - $8,209
249 Added 1.44%
17,598 $497,000
Q2 2024

Jul 19, 2024

SELL
$19.12 - $31.93 $92,636 - $154,700
-4,845 Reduced 21.83%
17,349 $331,000
Q1 2024

Apr 22, 2024

SELL
$29.41 - $34.72 $34,145 - $40,309
-1,161 Reduced 4.97%
22,194 $727,000
Q4 2023

Jan 16, 2024

SELL
$23.63 - $33.52 $121,410 - $172,225
-5,138 Reduced 18.03%
23,355 $771,000
Q3 2023

Oct 24, 2023

SELL
$25.0 - $31.4 $399,650 - $501,960
-15,986 Reduced 35.94%
28,493 $775,000
Q2 2023

Jul 25, 2023

BUY
$28.05 - $36.44 $4,684 - $6,085
167 Added 0.38%
44,479 $1.35 Million
Q1 2023

Apr 14, 2023

SELL
$26.35 - $35.8 $78,206 - $106,254
-2,968 Reduced 6.28%
44,312 $1.44 Million
Q4 2022

Feb 08, 2023

SELL
$22.21 - $37.41 $1.34 Million - $2.26 Million
-60,479 Reduced 56.12%
47,280 $1.33 Million
Q3 2022

Oct 25, 2022

BUY
$29.37 - $39.74 $1.23 Million - $1.67 Million
42,018 Added 63.91%
107,759 $3.87 Million
Q2 2022

Aug 12, 2022

SELL
$25.9 - $32.26 $19,062 - $23,743
-736 Reduced 1.11%
65,741 $2.02 Million
Q1 2022

May 11, 2022

SELL
$22.14 - $32.3 $454,113 - $662,505
-20,511 Reduced 23.58%
66,477 $2.15 Million
Q4 2021

Feb 08, 2022

BUY
$25.36 - $34.11 $264,910 - $356,313
10,446 Added 13.65%
86,988 $2.41 Million
Q3 2021

Nov 02, 2021

SELL
$20.93 - $31.0 $41,148 - $60,946
-1,966 Reduced 2.5%
76,542 $2.37 Million
Q2 2021

Aug 11, 2021

BUY
$18.43 - $21.78 $421,917 - $498,609
22,893 Added 41.16%
78,508 $1.66 Million
Q1 2021

May 14, 2021

BUY
$16.19 - $21.22 $47,112 - $61,750
2,910 Added 5.52%
55,615 $1.12 Million
Q4 2020

Feb 12, 2021

BUY
$9.92 - $16.43 $97,662 - $161,753
9,845 Added 22.97%
52,705 $845,000
Q3 2020

Nov 04, 2020

SELL
$7.4 - $14.33 $7,059 - $13,670
-954 Reduced 2.18%
42,860 $532,000
Q2 2020

Jul 28, 2020

BUY
$4.8 - $9.42 $163 - $320
34 Added 0.08%
43,814 $312,000
Q1 2020

Apr 21, 2020

BUY
$3.64 - $11.77 $9,045 - $29,248
2,485 Added 6.02%
43,780 $238,000
Q4 2019

Feb 12, 2020

SELL
$6.49 - $10.68 $44,151 - $72,656
-6,803 Reduced 14.14%
41,295 $374,000
Q3 2019

Nov 07, 2019

BUY
$5.82 - $8.31 $137,014 - $195,634
23,542 Added 95.87%
48,098 $346,000
Q2 2019

Aug 06, 2019

SELL
$7.71 - $14.54 $49,706 - $93,739
-6,447 Reduced 20.79%
24,556 $195,000
Q1 2019

May 06, 2019

BUY
$12.17 - $20.92 $38,968 - $66,985
3,202 Added 11.52%
31,003 $390,000
Q4 2018

Feb 11, 2019

BUY
$17.75 - $27.2 $211,349 - $323,870
11,907 Added 74.92%
27,801 $555,000
Q3 2018

Nov 14, 2018

SELL
$20.1 - $28.75 $10,773 - $15,410
-536 Reduced 3.26%
15,894 $451,000
Q2 2018

Aug 14, 2018

BUY
$13.8 - $23.95 $3,546 - $6,155
257 Added 1.59%
16,430 $346,000
Q1 2018

May 14, 2018

BUY
$12.8 - $16.5 $20,147 - $25,971
1,574 Added 10.78%
16,173 $230,000
Q4 2017

Feb 14, 2018

BUY
$10.5 - $18.7 $178 - $317
17 Added 0.12%
14,599 $180,000
Q3 2017

Nov 13, 2017

SELL
$15.65 - $24.75 $406 - $643
-26 Reduced 0.18%
14,582 $260,000
Q2 2017

Aug 14, 2017

BUY
N/A
14,608
14,608 $370,000

Others Institutions Holding EVH

About Evolent Health, Inc.


  • Ticker EVH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 97,063,696
  • Market Cap $2.38B
  • Description
  • Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...
More about EVH
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.